Patent directory · USPTO A61K / A61P
Patents matching “targeted”
263 pharma patents match "targeted" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 263 pharmaceutical patents matching "targeted" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11161908
BAFF-R targeted chimeric antigen receptor-modified t-cells and uses thereof
granted -
US 11147883
Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells
granted -
US 11149321
Methods and compositions for targeted single-stranded cleavage and targeted integration
granted -
US 11130783
CD40 targeted peptides and uses thereof
granted -
US 11098025
Bi-functional compounds and methods for targeted ubiquitination of androgen receptor
granted -
US 11083753
Targeted replacement of endogenous T cell receptors
granted -
US 11085022
Inflammation-targeted neutrophil granulocyte drug delivery system and use thereof
granted -
US 11084859
Targeted mutant interferon-gamma and uses thereof
granted -
US 11053495
Multi-targeted single entity conjugates
granted -
US 11033584
Targeted replacement of endogenous T cell receptors
granted -
US 11001610
Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof
granted -
US 10974235
Targeted, metal-catalyzed fluorination of complex compounds with fluoride ion via decarboxylation
granted -
US 10975158
CD138-targeted interferon demonstrates potent apoptotic and anti-tumor activities
granted -
US 10954516
GNAQ targeted dsRNA compositions and methods for inhibiting expression
granted -
US 10947317
NaPi2b-targeted antibody-drug conjugates and methods of use thereof
granted -
US 10918668
Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases
granted -
US 10906985
Targeted engineered interferon and uses thereof
granted -
US 10889834
Methods and compositions for enhancing targeted transgene integration
granted -
US 10881735
Phase change nanodroplet conjugates for targeted delivery
granted -
US 10875893
Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods
granted -
US 10874610
Extracellular vesicle-based diagnostics and engineered exosomes for targeted therapeutics against cancer
granted -
US 10864270
Nanostructured carriers for guided and targeted on-demand substance delivery
granted -
US 10849875
Cancer specific lipid targeted peptidomimetics
granted -
US 10828315
Targeted therapeutics
granted